• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

CHAI | Leading the Ethical AI Revolution in Healthcare

Share:

March 20, 2024

CHAI, with founding partners including Amazon, CVS, Google, Mayo Clinic, and Stanford, aims to establish ethical AI standards in healthcare. Collaborating with the National Academy of Medicine, it promotes responsible AI development. CHAI offers open membership, plans for tiered benefits, and seeks to foster innovation through industry collaboration, ensuring AI serves patients’ best interests.

Amazon, CVS, Google, Mayo Clinic, Stanford, and Others Pave the Way for Ethical AI in Healthcare: A Deep Dive into the Coalition for Health AI (CHAI) and Its Founding Partners

In a landmark announcement, the Coalition for Health AI (CHAI) heralded a momentous occasion with the formation of its founding partner group. This diverse consortium brings together a formidable array of stakeholders, spanning non-profit research institutions, patient advocacy organizations, healthcare providers, and major technology corporations. At its core, CHAI is dedicated to fostering trustworthy AI applications for the betterment of healthcare.

Mission and Objectives: Forging a Path towards Responsible AI

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Central to CHAI’s mission is the establishment of a preeminent resource dedicated to responsible AI practices within the healthcare domain. The coalition’s objectives are multifaceted:

1. Development of Best Practices: CHAI endeavors to spearhead the formulation of industry-leading standards for the testing, deployment, and evaluation of AI-driven healthcare systems. By defining best practices, CHAI aims to instill trust and reliability in AI applications across the healthcare spectrum.

2. Promotion of Innovation and Collaboration: Embracing a collaborative ethos, CHAI seeks to cultivate an environment conducive to innovation within the healthcare AI landscape. Through cross-sector partnerships and knowledge-sharing initiatives, the coalition endeavors to advance responsible experimentation and foster the dissemination of insights. This encompasses leveraging both conventional machine learning methodologies and cutting-edge advancements such as generative AI.

Founding Partners: Champions of Responsible AI Adoption

The founding partners of CHAI epitomize a diverse tapestry of healthcare and technology luminaries. Notable non-profit founding partners include esteemed institutions such as AdventHealth, Boston Children’s Hospital, Duke Health, Johns Hopkins Medicine, Mayo Clinic, and Stanford Medicine, among others. These entities are at the vanguard of healthcare innovation, committed to driving ethical AI adoption and ensuring patient-centric care delivery.

On the industry front, CHAI boasts the participation of tech titans including Amazon, CVS Health, Google, and Microsoft. With their unparalleled technological prowess and vast resources, these industry leaders are poised to catalyze transformative advancements in healthcare AI while upholding principles of ethical conduct and patient welfare.

Collaboration with the National Academy of Medicine: Pioneering Ethical AI Frameworks

In a strategic alliance, CHAI has joined forces with the esteemed National Academy of Medicine (NAM) to support and advance the NAM’s Artificial Intelligence Code of Conduct (AICC) project. This collaborative endeavor aims to develop a comprehensive framework delineating ethical guidelines for AI development and deployment in healthcare and biomedicine. By aligning with the NAM’s esteemed expertise, CHAI endeavors to fortify the ethical underpinnings of AI-driven healthcare solutions, thereby engendering public trust and confidence.

Open Membership and Future Prospects: Charting the Course Ahead

CHAI extends an open invitation to all interested parties to join its ranks and contribute to the collective mission of promoting responsible AI in healthcare. Looking ahead, the coalition plans to introduce tiered membership options later in 2024, offering stakeholders access to a plethora of exclusive benefits. These perks include participation in annual conferences, access to educational resources and publications, and specialized tools for quality assurance. Through these initiatives, CHAI aims to galvanize a global community of stakeholders united in their commitment to harnessing the power of AI for the betterment of healthcare delivery and outcomes.

In essence, the formation of CHAI and the involvement of its founding partners signify a pivotal juncture in the evolution of AI-driven healthcare. By championing responsible AI practices and fostering collaboration among diverse stakeholders, CHAI endeavors to pave the way for a future where technology serves as a catalyst for positive transformation in healthcare delivery and patient outcomes.

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • LOTTE to Purchase Bristol Myers Squibb Manufacturing Facility in East Syracuse, New YorkLOTTE to Purchase Bristol Myers Squibb Manufacturing Facility in East Syracuse, New York
  • Idera Bolsters Rare Disease Portfolio with Aceragen BuyoutIdera Bolsters Rare Disease Portfolio with Aceragen Buyout
  • Curaleaf Expands Footprint, Closes Glendale Greenhouse AcquisitionCuraleaf Expands Footprint, Closes Glendale Greenhouse Acquisition
  • Ampersand Capital Partners Acquires American Laboratory Products CompanyAmpersand Capital Partners Acquires American Laboratory Products Company
  • FCC, HHS, and USDA Team Up for Rural Telehealth Initiative Task ForceFCC, HHS, and USDA Team Up for Rural Telehealth Initiative Task Force
  • Cytovale Secures $84M for Transformative Sepsis Diagnostic ToolCytovale Secures $84M for Transformative Sepsis Diagnostic Tool
  • Sanofi Rumored to Be Considering Acquisition of PrincipiaSanofi Rumored to Be Considering Acquisition of Principia
  • McKesson Corporation Announces Third-Quarter Fiscal 2023 Earnings Release DateMcKesson Corporation Announces Third-Quarter Fiscal 2023 Earnings Release Date

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications